 "Decision on Covaxin approval by August second week: WHO chief scientist")
World Health Organization Chief Scientist Soumya Swaminathan told NDTV on Thursday that the decision on emergency approval for Covaxin would be made next month. Developed by Bharat Biotech and the ICMR, Covaxin was approved by the Indian drug controller in January, and has been in use since.
“The decision on Covaxin approval will be made by the second week of August," Swaminathan said. Yesterday, Bharat Biotech's joint managing director Suchitra Ella said the vaccine will move towards emergency use listing. Approval from the WHO is not expected to be a long-drawn process.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%